Incyte Corp. sell BMO Capital Markets
Start price
02.07.24
/
50%
€54.76
Target price
02.07.25
€44.72
Performance (%)
8.51%
Price
30.08.24
€59.42
Summary
This prediction is currently active. With a performance of 8.51%, the SELL prediction by BMO_Capital_Markets for Incyte Corp. is trending in the wrong direction This prediction currently runs until 02.07.25. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Incyte Corp. | 3.664% | 3.664% |
iShares Core DAX® | 1.560% | 4.721% |
iShares Nasdaq 100 | 0.517% | 1.171% |
iShares Nikkei 225® | 1.730% | 6.073% |
iShares S&P 500 | 1.482% | 1.218% |
Comments by BMO_Capital_Markets for this prediction
In the thread Incyte Corp. diskutieren
Incyte Co. (NASDAQ: INCY) had its "underperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $48.00 price target on the stock, down previously from $52.00.
Ratings data for INCY provided by MarketBeat